Green Cross Corp
GC Biopharma Corp., a biopharmaceutical company, develops and sells pharmaceutical drugs in South Korea and internationally. It provides over-the-counter drugs, such as Acustop Cataplasma for Analgesic and anti-inflammatory effect; Kenhancer plaster for anti-inflammatory; and Zenol Cool Type and Zenol Mild Hot Type drugs to treat anti-inflammatory and pain relief. The company also offers Albumin-… Read more
Green Cross Corp (006280) - Total Assets
Latest total assets as of September 2025: ₩3.19 Trillion KRW
Based on the latest financial reports, Green Cross Corp (006280) holds total assets worth ₩3.19 Trillion KRW as of September 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Green Cross Corp - Total Assets Trend (2003–2024)
This chart illustrates how Green Cross Corp’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Green Cross Corp - Asset Composition Analysis
Current Asset Composition (December 2024)
Green Cross Corp's total assets of ₩3.19 Trillion consist of 43.8% current assets and 56.2% non-current assets.
| Asset Category | Amount (KRW) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | ₩0.00 | 0.8% |
| Accounts Receivable | ₩386.53 Billion | 14.1% |
| Inventory | ₩746.58 Billion | 27.2% |
| Property, Plant & Equipment | ₩0.00 | 0.0% |
| Intangible Assets | ₩181.77 Billion | 6.6% |
| Goodwill | ₩125.61 Billion | 4.6% |
Asset Composition Trend (2003–2024)
This chart illustrates how Green Cross Corp's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Green Cross Corp's current assets represent 43.8% of total assets in 2024, an increase from 0.0% in 2003.
- Cash Position: Cash and equivalents constituted 0.8% of total assets in 2024, down from 3.2% in 2003.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 10.0% of total assets, an increase from 4.0% in 2003.
- Asset Diversification: The largest asset category is inventory at 27.2% of total assets.
Green Cross Corp Competitors by Total Assets
Key competitors of Green Cross Corp based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Swedish Orphan Biovitrum AB (publ)
PINK:BIOVF
|
USA | $67.26 Billion |
|
Dongwha Pharm.Co.Ltd
KO:000020
|
Korea | ₩654.63 Billion |
|
Shenzhen Neptunus Bioengineering Co Ltd
SHE:000078
|
China | CN¥27.28 Billion |
|
Yuhan Corp Preferred
KO:000105
|
Korea | ₩3.05 Trillion |
|
Anhui Fengyuan Pharmaceutical Co Ltd
SHE:000153
|
China | CN¥4.97 Billion |
|
Kotra Industries Bhd
KLSE:0002
|
Malaysia | RM363.90 Million |
|
Yuyu Pharma
KO:000220
|
Korea | ₩202.42 Billion |
|
Ildong Holdings Co Ltd
KO:000230
|
Korea | ₩813.62 Billion |
Green Cross Corp - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Moderate asset utilization - Green Cross Corp generates 0.61x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Negative ROA - Green Cross Corp is currently not profitable relative to its asset base.
Green Cross Corp - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.18 | 1.55 | 1.92 |
| Quick Ratio | 0.51 | 0.70 | 1.18 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | ₩223.84 Billion | ₩ 432.09 Billion | ₩ 542.64 Billion |
Green Cross Corp - Advanced Valuation Insights
This section examines the relationship between Green Cross Corp's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 1.15 |
| Latest Market Cap to Assets Ratio | 0.00 |
| Asset Growth Rate (YoY) | 3.8% |
| Total Assets | ₩2.74 Trillion |
| Market Capitalization | $556.71 Million USD |
Valuation Analysis
Below Book Valuation: The market values Green Cross Corp's assets below their book value (0.00 x), which may indicate investor concerns about asset quality or future growth.
Positive Asset Growth: Green Cross Corp's assets grew by 3.8% over the past year, showing continued investment in the company's operational capacity.
Annual Total Assets for Green Cross Corp (2003–2024)
The table below shows the annual total assets of Green Cross Corp from 2003 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | ₩2.74 Trillion | +3.80% |
| 2023-12-31 | ₩2.64 Trillion | +4.66% |
| 2022-12-31 | ₩2.53 Trillion | +2.57% |
| 2021-12-31 | ₩2.46 Trillion | +14.44% |
| 2020-12-31 | ₩2.15 Trillion | +9.80% |
| 2019-12-31 | ₩1.96 Trillion | +13.69% |
| 2018-12-31 | ₩1.72 Trillion | +1.16% |
| 2017-12-31 | ₩1.70 Trillion | +9.86% |
| 2016-12-31 | ₩1.55 Trillion | +9.57% |
| 2015-12-31 | ₩1.42 Trillion | +6.37% |
| 2014-12-31 | ₩1.33 Trillion | +20.47% |
| 2013-12-31 | ₩1.10 Trillion | +15.70% |
| 2012-12-31 | ₩954.38 Billion | +10.93% |
| 2011-12-31 | ₩860.35 Billion | +16.06% |
| 2010-12-31 | ₩741.30 Billion | +104.40% |
| 2006-12-31 | ₩362.68 Billion | +22.22% |
| 2005-12-31 | ₩296.73 Billion | +18.32% |
| 2004-12-31 | ₩250.79 Billion | +184.80% |
| 2003-12-31 | ₩88.06 Billion | -- |